Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Stephen Oxley bought 27 shares of Johnson Matthey stock in a transaction that occurred on Wednesday, February 19th. The stock was bought at an average cost of GBX 1,451 ($18.39) per share, with a total value of £391.77 ($496.41).
Stephen Oxley also recently made the following trade(s):
- On Wednesday, November 27th, Stephen Oxley purchased 7,407 shares of Johnson Matthey stock. The shares were acquired at an average cost of GBX 1,343 ($17.02) per share, with a total value of £99,476.01 ($126,046.64).
Johnson Matthey Price Performance
Shares of Johnson Matthey stock opened at GBX 1,449.05 ($18.36) on Friday. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 62.73. Johnson Matthey PLC has a twelve month low of GBX 1,295.54 ($16.42) and a twelve month high of GBX 1,917.07 ($24.29). The company has a 50-day simple moving average of GBX 1,382.14 and a two-hundred day simple moving average of GBX 1,481.39. The stock has a market capitalization of £2.42 billion, a price-to-earnings ratio of 24.62, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95.
Johnson Matthey Cuts Dividend
The firm also recently disclosed a dividend, which was paid on Tuesday, February 4th. Investors of record on Thursday, December 5th were given a dividend of GBX 22 ($0.28) per share. The ex-dividend date of this dividend was Thursday, December 5th. This represents a dividend yield of 1.47%. Johnson Matthey’s dividend payout ratio is currently 130.84%.
Analyst Ratings Changes
JMAT has been the subject of several analyst reports. Berenberg Bank decreased their price objective on Johnson Matthey from GBX 1,650 ($20.91) to GBX 1,500 ($19.01) and set a “hold” rating for the company in a report on Thursday, November 28th. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 1,800 ($22.81) price objective on shares of Johnson Matthey in a report on Tuesday, December 17th.
Check Out Our Latest Stock Analysis on Johnson Matthey
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
See Also
- Five stocks we like better than Johnson Matthey
- When to Sell a Stock for Profit or Loss
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- What Investors Need to Know to Beat the Market
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- What is the FTSE 100 index?
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.